Anupam Rasayan Executes USD 50 Million Credit Facilities for Luxembourg Expansion

2 min read     Updated on 12 Feb 2026, 08:00 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Anupam Rasayan India Limited has executed comprehensive credit facilities totaling USD 50 million on February 14, 2026, to support its Luxembourg expansion strategy. The financing includes USD 20 million from Altis XII Pte. Ltd. and USD 30 million ECB from Axis Bank Limited, backed by extensive security arrangements including corporate guarantees of USD 150 million aggregate coverage.

32452251

*this image is generated using AI for illustrative purposes only.

Anupam Rasayan India Limited has executed comprehensive credit facilities totaling USD 50,000,000 on February 14, 2026, following the successful completion of its strategic Luxembourg acquisitions. The company disclosed the execution of multiple financing agreements and security arrangements under Regulation 30 of SEBI Listing Regulations.

Luxembourg Acquisition Completion

The company has successfully completed its overseas expansion through two key acquisitions in Luxembourg:

Entity Acquisition Details Status
Doriath S.à r.l. 12,000 shares (100% stake) from Palaos S.à r.l. Completed February 10, 2026
Batam S.à r.l. 1,800 shares (15% stake) from Palaos S.à r.l. Consideration paid, completion in process

Doriath S.à r.l., registered under Luxembourg Trade and Companies Register number B300157, was incorporated on September 29, 2025. Batam S.à r.l., registered under number B301756, was incorporated on November 14, 2025. Both entities will focus on consultancy services and are registered at 9, rue de Bitbourg, L-1273 Luxembourg.

Credit Facility Execution Details

On February 14, 2026, the company executed two major credit facilities to support the acquisitions:

Facility Type Amount Lender Purpose
Credit Facilities USD 20,000,000 Altis XII Pte. Ltd. Fund Target Group acquisition by Doriath
External Commercial Borrowing USD 30,000,000 Axis Bank Limited, IBU GIFT City Overseas Direct Investment loan to Doriath

The Credit Facilities will be utilized to fund the partial consideration for Doriath's acquisition of 100% share capital in Monitchem Kansas S.à r.l. and an intragroup loan receivable. The ECB Facility proceeds will support Overseas Direct Investment in Doriath through a loan not exceeding USD 20,000,000.

Comprehensive Security Framework

The financing arrangements involve extensive security measures and corporate guarantees:

Security Type Details Beneficiary
Corporate Guarantees USD 150,000,000 aggregate coverage Catalyst Trusteeship Limited
Hypothecation Charge First ranking pari passu over movable fixed assets Security agents
Mortgage Charge First ranking pari passu over immovable properties Security agents
Share Pledge Exclusive pledge over Doriath and Batam shares Altis XII Pte. Ltd.
Non-Disposal Undertaking 25.80% shareholding in Tanfac Industries Limited Security agents

Catalyst Trusteeship Limited has been appointed as the onshore security trustee for the Credit Facilities, while Axis Trustee Services Limited serves as the security agent for the ECB Facility.

Strategic Investment Structure

Batam has agreed to invest USD 110,000,001 into Doriath pursuant to a share subscription agreement dated February 12, 2026. The investment proceeds will be used by Doriath to partially fund the acquisition of 100% share capital in Monitchem Kansas S.à r.l. and an intragroup loan receivable, in accordance with the Sale and Purchase Agreement dated December 9, 2025, with CABB Europe GmbH.

The transactions with Doriath constitute related party transactions as it is a wholly-owned subsidiary, while the company maintains no shareholding in Altis XII Pte. Ltd. or Catalyst Trusteeship Limited. All related party transactions are conducted on an arm's length basis, with the company receiving guarantee fees and commissions for issuing corporate guarantees.

Source:

Historical Stock Returns for Anupam Rasayan

1 Day5 Days1 Month6 Months1 Year5 Years
-0.76%-1.34%-5.45%+11.19%+64.18%+134.42%

Anupam Rasayan India Limited Schedules Q3FY26 Earnings Call for February 14, 2026

1 min read     Updated on 10 Feb 2026, 06:47 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Anupam Rasayan India Limited has scheduled its Q3FY26 earnings call for February 14, 2026, at 15:00 hrs IST to discuss financial results for the quarter and nine months ended December 31, 2025. The call will feature senior management including MD Mr. Anand Desai, CEO Mr. Gopal Agrawal, and CFO Mr. Amit Khurana. The specialty chemicals manufacturer serves 71+ customers including 27+ multinationals through six Gujarat-based facilities with 30,000 MT aggregate capacity.

32275061

*this image is generated using AI for illustrative purposes only.

Anupam Rasayan India Limited has scheduled its earnings call to discuss the financial performance for the third quarter and nine months of Financial Year 2025-26. The company will announce its unaudited financial results for the quarter and nine months ended December 31, 2025, followed by a management discussion on February 14, 2026.

Earnings Call Details

The earnings conference call is scheduled for Saturday, February 14, 2026, at 15:00 hrs IST. The company has made comprehensive arrangements for stakeholder participation through multiple access channels.

Parameter: Details
Date: Saturday, February 14, 2026
Time: 15:00 hrs IST
Universal Access Numbers: +91 22 6280 1107, +91 22 7115 8008
USA Toll-Free: 18667462133
UK Toll-Free: 08081011573
Singapore Toll-Free: 8001012045
Hong Kong Toll-Free: 800964448

Management Representation

The earnings call will feature senior management representatives who will discuss the company's financial performance and business developments:

  • Mr. Anand Desai - Managing Director
  • Mr. Gopal Agrawal - Chief Executive Officer
  • Mr. Amit Khurana - Chief Financial Officer
  • Mr. Vishal Thakkar - Deputy Chief Financial Officer

Participants are requested to dial-in 5 minutes before the scheduled time to ensure smooth connectivity.

Company Overview

Anupam Rasayan India Limited is a leading specialty chemicals manufacturer incorporated in 1984, specializing in custom synthesis and manufacturing. The company operates through two main verticals: Life Science related Specialty Chemicals covering Agrochemicals, Personal Care and Pharmaceuticals, and Other Specialty Chemicals including Specialty Pigments, Dyes, and Polymer Additives.

Business Parameter: Details
Customer Base: 71+ domestic and international customers
Multinational Clients: 27+ companies
Manufacturing Facilities: 6 facilities in Gujarat
Facility Locations: 4 at Sachin, Surat; 2 at Jhaghadia, Bharuch
Aggregate Installed Capacity: About 30,000 MT as of March 31, 2025

Regulatory Compliance

The earnings call announcement has been made in compliance with Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has informed both BSE Limited and National Stock Exchange of India Limited about the scheduled earnings call, with the intimation also hosted on the company's website at www.anupamrasayan.com .

Historical Stock Returns for Anupam Rasayan

1 Day5 Days1 Month6 Months1 Year5 Years
-0.76%-1.34%-5.45%+11.19%+64.18%+134.42%

More News on Anupam Rasayan

1 Year Returns:+64.18%